Fatma Elsayed

ORCID: 0009-0001-2271-734X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Pediatric health and respiratory diseases
  • Renal Diseases and Glomerulopathies
  • Systemic Lupus Erythematosus Research
  • Platelet Disorders and Treatments
  • Respiratory Support and Mechanisms

Al-Azhar University
2024

Ain Shams University
2021

Menoufia University Hospitals
2020

<b>Aim: </b>To evaluate the relationships between sputum and bronchoalveolar lavage (BAL) cellular bacterial findings severity of exacerbation chronic obstructive pulmonary disease (ECOPD).<br /> <b>Patients & methods: </b>A cross-section study was conducted on 307 patients with ECOPD. They underwent BAL inflammatory cell count culture.<br <b>Results:</b> Patients severe ECOPD have significantly higher neutrophils percentage (neut.%),...

10.29333/ejgm/14200 article EN Electronic Journal of General Medicine 2024-02-12

Background: little is recognized on the role eosinophils in pathophysiology of acute exacerbation chronic obstructive pulmonary disease (AECOPD).Objective: To assess relationship between eiosinophilic AECOPD and sputum inflammation bacterial load. Methodology:A cross-sectional study was done 80 out 189 patients presented by clinical picture AECOPD.Spirometry, total differential leucocytic count (TLC), load culture were for all participants.They divided into two subgroups based blood %;...

10.21608/jram.2020.23857.1038 article EN Journal of Recent Advances in Medicine/Journal of Recent Advances in Medicine 2020-02-27

Introduction: Podocyturia can be considered as a noninvasive marker for evaluation and follow up of glomerular disease progression. Objectives: In this study, we aimed to assess the clinical utility urinary podocin an index lupus nephritis activity. Patients Methods: This cross-sectional study included 45 patients with systemic erythematosus (SLE). were subdivided into three groups: group (I) 10 SLE, without or laboratory evidence (LN), which assessed by Systemic Lupus Activity Measure...

10.34172/jnp.2022.17268 article EN cc-by Journal of Nephropathology 2021-12-11
Coming Soon ...